Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk.
Background. Waist girth and BMI are commonly used as markers of cardiometabolic risk. Accumulating data however suggest that sagittal abdominal diameter (SAD) or "abdominal height" may be a better marker of intra-abdominal adiposity and cardiometabolic risk. We aimed to identify cutoffs for SAD using a cardiometabolic risk score. Design. A population-based cross-sectional study. Methods. In 4032 subjects (1936 men and 2096 women) at age 60, different anthropometric variables (SAD, BMI, waist girth, and waist-to-hip ratio) were measured and cardiometabolic risk score calculated. ROC curves were used to assess cutoffs. Results. Among men SAD showed the strongest correlations to the majority of the individual risk factors; whereas in women SAD was equal to that of waist girth. In the whole sample, the area under the ROC curve was highest for SAD. The optimal SAD cutoff for an elevated cardiometabolic risk score in men was approximately 22 cm (95%CI; 21.6 to 22.8) and in women approximately 20 cm (95%CI; 19.4 to 20.8). These cutoffs were similar if the Framingham risk score was used. Conclusions. These cutoffs may be used in research and screening to identify "metabolically obese" men who would benefit from lifestyle and pharmacological interventions. These results need to be verified in younger age groups.
Risérus
U
U
Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, 75185 Uppsala, Sweden.
de Faire
U
U
Berglund
L
L
Hellénius
M-L
ML
J Hypertens. 2001 Dec;19(12):2157-64
11725158
BMJ. 1996 May 11;312(7040):1227-8
8634585
J Clin Pathol. 1969 Mar;22(2):158-61
5776547
BMJ. 1995 Nov 25;311(7017):1401-5
8520275
Int J Obes Relat Metab Disord. 2000 Apr;24(4):497-501
10805508
Int J Obes Relat Metab Disord. 1993 Nov;17(11):669
8135939
World Health Organ Tech Rep Ser. 1995;854:1-452
8594834
Am J Clin Nutr. 1988 Dec;48(6):1351-61
3202084
Am J Clin Nutr. 2006 Nov;84(5):1193-9
17093174
Clin Chem. 1974 Apr;20(4):470-5
4818200
J Clin Epidemiol. 1996 Sep;49(9):1017-24
8780611
Int J Obes Relat Metab Disord. 1995 Mar;19(3):169-74
7780492
Circulation. 2004 Nov 2;110(18):2781-5
15492315
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1401-4
6426576
Clin Chem. 1982 Oct;28(10):2077-80
6812986
Obes Res. 1999 May;7(3):256-64
10348496
Br J Nutr. 2000 Mar;83 Suppl 1:S71-7
10889795
Diabetes Metab. 2007 Feb;33(1):30-6
17258927
Cancer. 1950 Jan;3(1):32-5
15405679
BMJ. 2005 Jun 11;330(7504):1363-4
15833749
Int J Obes Relat Metab Disord. 1994 Jan;18(1):61-7
8130817
Am J Clin Nutr. 2006 Nov;84(5):995-1002
17093149
Clin Chem. 1998 Aug;44(8 Pt 1):1641-9
9702950
Lancet. 2006 Aug 19;368(9536):666-78
16920472
Cardiovasc Diabetol. 2007 Mar 28;6:10
17391519
Diabetes Care. 2004 Aug;27(8):2041-6
15277437
Am J Cardiol. 1994 Mar 1;73(7):460-8
8141087
Am J Epidemiol. 2006 Dec 15;164(12):1150-9
17041127
Diabetes. 1993 Feb;42(2):273-81
8425663
Clin Chem. 1972 Jun;18(6):499-502
4337382
Am J Cardiol. 1996 Oct 15;78(8):961-4
8888678
Br J Nutr. 1993 Jul;70(1):47-58
8399118
Obes Res. 1997 Nov;5(6):519-30
9449135
Am J Epidemiol. 2000 May 1;151(9):885-91
10791561
Int J Obes Relat Metab Disord. 2002 Feb;26(2):208-13
11850752
Nutr Metab Cardiovasc Dis. 2007 Jun;17(5):349-57
17562572
Obes Res. 1993 May;1(3):206-22
16350574
BMJ. 1997 Mar 15;314(7083):830
9081022
BMJ. 2001 Mar 24;322(7288):716-20
11264213
Thromb Res. 1984 Sep 1;35(5):475-84
6484895
Biometrics. 1988 Sep;44(3):837-45
3203132
Int J Obes Relat Metab Disord. 2000 May;24(5):652-7
10849590